Search clinical trials for: Rotavirus Vaccine, Live, Pentavalent

Total 801 results

Merck Sharp & Dohme LLC

Completed

V260 Registration Study (V260-013)(COMPLETED)

Rotavirus
Merck Sharp & Dohme LLC

Completed

Safety,Tolerability and Immunogenicity of Vaccination With Rotateq in Healthy Infants in India (V260-021)

Gastroenteritis | Rotavirus
Merck Sharp & Dohme LLC

Completed

Consistency Lots Vaccine Study (V260-009)

Rotavirus Infections
Children's Hospital of Michigan
Merck Sharp & Dohme LLC; Boston Children's Hospital; William Beaumont Hospitals

Completed

Safety and Immunogenicity of Rotavirus Vaccine (RotaTeq(R)) in Infants With Short Bowel Syndrome

Short Bowel Syndrome

United States
Merck Sharp & Dohme LLC

Completed

V260 Study: Concomitant Use of V260 and INFANRIX™ Hexa in Healthy Infants (V260-010)

Rotavirus Disease
Merck Sharp & Dohme LLC

Completed

Concomitant Use and Staggered Use of Vaccine and Oral Poliovirus (OPV) in Healthy Infants (V260-014)(COMPLETED)

Gastroenteritis | Rotavirus Infections
Merck Sharp & Dohme LLC

Completed

Dose Confirmation Efficacy Study (V260-007)

Rotavirus Infections
Merck Sharp & Dohme LLC

Completed

Developing World Study for RotaTeq™ (V260-015)(COMPLETED)

Vomiting | Diarrhea | Fever
Merck Sharp & Dohme LLC

Completed

Phase III Placebo-controlled Study of V260 (RotaTeq™) in Japanese Healthy Infants (V260-029)(COMPLETED)

Gastroenteritis | Rotavirus
Merck Sharp & Dohme LLC

Completed

A Study of V260 in Healthy Chinese Adults, Children and Infants (V260-028)(COMPLETED)

Rotavirus Gastroenteritis
Dennis Clements
Merck Sharp & Dohme LLC

Completed

An Alternate Dosing Schedule for Pentavalent Rotavirus Vaccine (RotaTeq)

Gastroenteritis | Diarrhea

United States
Serum Institute of India Pvt. Ltd.
PATH

Completed

A Clinical Trial to Study the Effect and Safety of Rotavirus Vaccine Against Severe Rotavirus Gastroenteritis in Healthy Indian Infants

Rotavirus Gastroenteritis

India
GlaxoSmithKline

Completed

Study of Immunogenicity & Safety of 2 Different Formulations of Human Rotavirus (HRV) Vaccine for the Prophylaxis of Rotavirus Gastroenteritis

Infections, Rotavirus

Finland
GlaxoSmithKline

Completed

Assess the Immunogenicity & Safety of 2 Doses of Oral Live Attenuated Human Rota(HRV)Vaccine in Healthy Infants in India

Infections, Rotavirus

India
GlaxoSmithKline

Completed

Assess the Immunogenicity of the Human Rotavirus (HRV) Vaccine After Reconstitution Without Buffering Agent; & Evaluate the Immunogenicity, Reactogenicity & Safety of the Vaccine After Storage for 7 d at 37°C Following 2 Doses in Healthy Infants

Rotavirus Gastroenteritis

Thailand
GlaxoSmithKline

Completed

Study of 2 Doses of Oral Live Attenuated Human Rotavirus (HRV) Vaccine for the Prophylaxis of Rotavirus Gastroenteritis

Infections, Rotavirus

Korea, Republic of
Sichuan Center for Disease Control and Prevention
China National Biotec Group Company Limited

Unknown

The Safety and Immunogenicity Study of Rotavirus Vaccine Simultaneously Vaccinated With MR or MMR Vaccine

Rotavirus
Bharat Biotech International Limited
Indian Council of Medical Research; National Institutes of Health (NIH); Stanford... and other collaborators

Completed

Dose Escalation Study to Evaluate Oral Rotavirus Vaccine 116E Live Attenuated in Healthy Infants 8 to 20 Weeks Old

Diarrhea

India
PATH

Completed

Coadministration of Measles-rubella and Rotavirus Vaccines

Measles Antibody Seroconversion | Rubella Antibody Seroconversion | Rotavirus Geometric Mean Titer (GMT) | Rotavirus Immunoglobulin A (IgA) Seropositivity

Bangladesh
Merck Sharp & Dohme LLC

Withdrawn

A Study of the Immunogenicity and Safety of Whole-Cell Pertussis Containing Vaccine Administered Concomitantly With RotaTeq™ (V260) or Rotarix™ (V260-036)(WITHDRAWN)

Pertussis | Tetanus | Diphtheria | Rotavirus Gastroenteritis
Sanofi Pasteur, a Sanofi Company

Completed

Study of a Pneumococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Toddlers and Infants

Pertussis Immunisation | Diphtheria Immunisation | Tetanus Immunisation | Pneumococcal Immunisation | Hepatitis B Immunisation | Haemophilus Influenzae Type b Immunisation | Polio Immunisation | Measles Immunisation | Rubella Immunisation | Varicella Immunisation | Mumps Immunisation

United States, Canada, Honduras, Puerto Rico
Academisch Medisch Centrum - Universiteit van Amsterdam...
Centers for Disease Control and Prevention; Wageningen University and Research

Completed

The Role of the Intestinal Microbiome in Enteric and Systemic Vaccine Immune Responses (Rota-biome)

Tetanus | Rotavirus Infections | Reaction - Vaccine Nos | Intestinal Bacteria Flora Disturbance | Streptococcal Pneumonia

Netherlands
Butantan Institute

Completed

Rotavirus Vaccine Produced by Butantan Institute

Rotavirus Infections

Brazil
University of Oxford
Malaria Research and Training Center, Bamako, Mali

Active, not recruiting

Assessment of Safety and Immunogenicity of a Single Vial Presentation of R21/Matrix-M and Co-Administration With EPI Vaccines

Malaria

Mali, United Kingdom
PATH
University of Maryland; Center for Vaccine Development - Mali

Completed

Immune Response to Rotavirus Vaccine After a Supplemental Dose Given at 9 Months of Age With Local EPI Vaccines in Mali

Diarrhea Rotavirus

Mali
Shantha Biotechnics Limited

Unknown

Safety and Immunogenicity Study of the Tetravalent Rotavirus Vaccine

Rotavirus Gastroenteritis

India
GlaxoSmithKline

Completed

Study of 2 Doses of HRV Vaccine Given Concomitantly or Separately With Routine Vaccinations in Healthy Infants in USA

Infections, Rotavirus

United States
GlaxoSmithKline

Completed

A Study in Infants to Test Two Preparations (Freeze-dried or Liquid) of the Rotavirus Vaccine (HRV Vaccine).

Infections, Rotavirus

Finland
GlaxoSmithKline

Completed

Study of 2 Doses of HRV Vaccine Given Concomitantly With Routine EPI Vaccinations Including OPV in Healthy Infants

Infections, Rotavirus

Argentina, Brazil, Dominican Republic, Panama, Colombia, Honduras
Novartis Vaccines

Completed

A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Infants

Meningitis, Meningococcal

United States, Argentina, Colombia
Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd

Active, not recruiting

Phase I Clinical Trial of Inactivated Rotavirus Vaccine in a Population Aged 6 Weeks-49 Years Old

Healthy Volunteers

China
Limited Liability Company Pharm Aid

Completed

Safety and Immunological Efficacy of the Pentavalent Rotavirus Vaccine - Rota-V-Aid™ (Live Attenuated Oral, Freeze-dried) at Healthy Adults Aged 18 to 45 Years.

Rotavirus Infections | Rotavirus Vaccines

Russian Federation
Limited Liability Company Pharm Aid

Completed

Reactogenicity, Safety and Immunological Efficacy of the Live, Pentavalent Rotavirus Vaccine in Childhood Immunization

Rotavirus Infection

Russian Federation
MSD Wellcome Trust Hilleman Laboratories Pvt. Ltd.
Parexel

Completed

Safety, Reactogenicity and Immunogenicity of Heat-stable Rotavirus Vaccine (HSRV) in Adults and Infants (HSRV)

Rotavirus Gastroenteritis

Bangladesh
Shantha Biotechnics Limited

Completed

A Study to Evaluate the Safety of Tetravalent Rotavirus Vaccine in Healthy Indian Adult Male Volunteers

Rotavirus Gastroenteritis

India
GlaxoSmithKline

Completed

Primary and Booster Vaccination Study With a Pneumococcal Vaccine in HIV Infected, HIV Exposed Uninfected and HIV Uninfected Children 6 to 10 Weeks of Age.

Infections, Streptococcal

South Africa
MAXVAX Biotechnology Limited Liability Company
Henan Center for Disease Control and Prevention

Active, not recruiting

Safety and Immunogenicity Study of Recombinant Trivalent Rotavirus Subunit Vaccine in Healthy Infants and Toddlers

Rotavirus Infections | Rotavirus Gastroenteritis

China
Sanofi Pasteur, a Sanofi Company

Completed

Concomitant Administration of a New Hexavalent Vaccine With a Meningococcal Serogroup C Conjugate Vaccine in Healthy Infants During Primary Series Immunisation Followed by Booster Vaccination

Virus Diseases | Bacterial Infections | Neisseria Meningitidis

Finland
National Institute of Allergy and Infectious Diseases...
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Completed

Pneumococcal Vaccine and Routine Pediatric Immunizations in HIV-Infected Children Receiving Anti-HIV Drugs

HIV Infections | Hepatitis B | Measles | Pneumococcal Infections | Pertussis

United States, Puerto Rico
International Centre for Diarrhoeal Disease Research...
National Institutes of Health (NIH); Centers for Disease Control and Prevention and other collaborators

Completed

Improving Rotavirus Vaccine Immune Response

Healthy Infants | Mothers

Bangladesh
Shantha Biotechnics Limited
PATH

Withdrawn

Safety and Immunogenicity Study of the Recombinant Human Bovine Reassortant Rotavirus Vaccine in Healthy Indian Infants

Rotavirus Infections

India
MCM Vaccines B.V.
Merck Sharp & Dohme LLC

Completed

Safety, Tolerability, and Immunogenicity of V419 in Healthy Infants When Given at 2, 4, and 11 to 12 Months (V419-008)

Virus Diseases | Bacterial Infections
Serum Institute of India Pvt. Ltd.
PATH

Completed

Phase III Study on Rotavirus Vaccine to Evaluate Lot-to-lot Consistency and Interference With Routine UIP Immunization

Rotavirus Gastroenteritis

India
National Institute of Allergy and Infectious Diseases...

Completed

ACAM 3000 MVA at Harvard Medical School

Smallpox

United States
Sanofi Pasteur, a Sanofi Company

Completed

Immunogenicity and Safety Study of a Quadrivalent Meningococcal Conjugate Vaccine Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers

Healthy Volunteers (Meningococcal Infection)

United States, Puerto Rico
National Institute of Allergy and Infectious Diseases...

Completed

Combination Study With MVA BN and Dryvax

Smallpox

United States
Federico II University
Merck Sharp & Dohme LLC

Not yet recruiting

A Surveillance Study on Timing and Coverage Of Rotavirus and MenB Vaccine Co-administration in Campania Region, Italy (STORM)

Meningococcal Infections | Rotavirus Infections | Vaccination
Centre for Infectious Disease Research in Zambia
Imperial College London; Christian Medical College, Vellore, India

Completed

Development of a Live Attenuated Rotavirus Vaccine as a Human Infection Challenge Model

Diarrhoeal Disease

Zambia
GlaxoSmithKline

Completed

To Test 2 Doses of GSK Biologicals' Oral Live Attenuated Human Rotavirus (HRV) Vaccine in Healthy Infants in Co-administration With Specific Childhood Vaccines

Infections, Rotavirus

Finland, Germany, Spain, Italy, France, Czech Republic
GlaxoSmithKline

Completed

To Evaluate 2 Doses of GSK Biologicals' Oral Live Attenuated Human HRV Vaccine Co-administered With Either OPV or IPV

Rotavirus Infections

South Africa

Search clinical trials for: Rotavirus Vaccine, Live, Pentavalent

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United States

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations